Wyndham Hotels & Resorts (WH) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
1 May, 2026Executive summary
Achieved 4% net room growth year-over-year, with system-wide rooms reaching 869,300 and a record pipeline of over 2,200 hotels and 259,000 rooms, up 3% year-over-year.
U.S. RevPAR was flat year-over-year but exceeded expectations by 250 basis points, while international growth offset flat U.S. performance.
Ancillary revenues grew 21% year-over-year, driven by renewed credit card partnerships and technology initiatives.
Adjusted EBITDA rose 8% to $156 million, with net income flat at $61 million and adjusted net income up 9% to $73 million.
Returned $85 million to shareholders through $51 million in share repurchases and $34 million in dividends.
Financial highlights
Net revenues for Q1 2026 were $327 million, up 3% year-over-year, driven by ancillary revenue growth and system expansion.
Adjusted EBITDA was $156 million (+8% year-over-year), with an industry-leading margin of 83%.
Adjusted diluted EPS was $0.96, down 3% on a comparable basis, while basic and diluted EPS increased to $0.80.
Free cash flow reached $64 million, with $42 million net cash from operating activities.
Ended the quarter with $1.1 billion in liquidity and a net leverage ratio of 3.5x.
Outlook and guidance
Reaffirmed full-year global net room growth guidance of 4.0–4.5% and raised global RevPAR outlook to a range of up 1% to down 1%.
Net revenues expected at $1.47–$1.5 billion; adjusted EBITDA guidance at $730–$745 million.
Adjusted net income outlook updated to $351–$365 million, with adjusted diluted EPS guidance at $4.62–$4.80.
Free cash flow conversion rate projected at 55–60%.
2026 capital expenditures expected at $40–$45 million; development advance notes investment at $110 million.
Latest events from Wyndham Hotels & Resorts
- Strong 2025 results, robust governance, and ESG focus; board opposes written consent proposal.WH
Proxy filing25 Mar 2026 - Annual meeting to vote on directors, pay, auditor, and written consent proposal.WH
Proxy filing25 Mar 2026 - Record room growth, resilient earnings, and strong capital returns despite RevPAR headwinds.WH
Q4 202519 Feb 2026 - Q2 saw 4% room growth, 22% higher adjusted EPS, and record pipeline expansion.WH
Q2 20242 Feb 2026 - Q3 delivered 4% room growth, $208M EBITDA, record pipeline, and raised 2024 guidance.WH
Q3 202418 Jan 2026 - Record system growth, strong earnings, and new initiatives drive a positive 2025 outlook.WH
Q4 202429 Dec 2025 - Record growth, strong financials, and robust governance drive positive outlook for 2025.WH
Proxy Filing1 Dec 2025 - Director elections, executive pay, and auditor ratification headline the annual meeting agenda.WH
Proxy Filing1 Dec 2025 - Record room and pipeline growth, but 2025 guidance lowered on RevPAR softness.WH
Q1 20251 Dec 2025